LSF
Laird Superfood, Inc. AMEX$3.10
Mkt Cap $33.9M
52w Low $1.96
19.1% of range
52w High $7.94
50d MA $2.63
200d MA $3.90
P/E (TTM)
-10.1x
EV/EBITDA
-5.8x
P/B
2.9x
Debt/Equity
0.0x
ROE
-28.4%
P/FCF
-8.2x
RSI (14)
—
ATR (14)
—
Beta
2.51
50d MA
$2.63
200d MA
$3.90
Avg Volume
58.7K
About
Laird Superfood, Inc. manufactures and markets plant-based natural and functional food in the United States. It offers powdered and liquid coffee creamers, and hydration and beverage enhancing supplements; hydrate coconut water products, activate daily jumpstart products, activate prebiotic daily greens, renew plant-based proteins, and performance mushroom supplements; coffee, tea, hot chocolate p…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 26, 2026 | AMC | -0.06 | -0.17 | -183.3% | 2.25 | -11.1% | -8.9% | -5.3% | -4.4% | +5.3% | +9.8% | +48.0% | — |
| Nov 10, 2025 | AMC | -0.04 | -0.03 | +25.0% | 4.18 | -28.0% | -31.1% | -35.2% | -33.7% | -36.1% | -40.0% | -42.8% | — |
| Aug 6, 2025 | AMC | -0.07 | -0.03 | +57.1% | 7.14 | -4.3% | -15.4% | -16.7% | -20.2% | -19.5% | -11.5% | -19.5% | — |
| May 7, 2025 | AMC | -0.07 | -0.02 | +71.4% | 6.72 | +4.0% | +4.9% | +11.6% | +12.5% | +11.6% | +10.4% | -0.1% | — |
| Feb 26, 2025 | AMC | -0.02 | -0.04 | -100.0% | 7.19 | -17.1% | -16.6% | -13.1% | -16.8% | -18.6% | -27.1% | -12.7% | — |
| Nov 6, 2024 | AMC | -0.06 | -0.05 | +16.7% | 7.37 | +8.5% | +21.7% | +24.3% | +35.5% | +21.6% | +14.0% | +22.1% | — |
| Aug 7, 2024 | AMC | -0.10 | -0.03 | +70.0% | 4.50 | +4.4% | +0.0% | -1.1% | -2.7% | +0.2% | -3.1% | -20.4% | — |
| May 8, 2024 | AMC | -0.20 | -0.11 | +45.0% | 2.64 | +10.2% | +4.9% | +1.9% | +1.5% | +1.5% | -1.5% | +64.8% | — |
| Mar 12, 2024 | AMC | -0.23 | 0.02 | +108.7% | 0.93 | +40.9% | +104.3% | +157.0% | +245.2% | +176.3% | +150.5% | +179.6% | — |
| Nov 8, 2023 | AMC | -0.35 | -0.28 | +20.0% | 0.85 | +4.7% | +5.8% | +2.5% | -13.0% | -5.5% | -2.4% | +23.5% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30 | Maxim Group | Maintains | Buy → Buy | — | $2.05 | $2.07 | +1.0% | +3.9% | +4.9% | +15.6% | +20.5% | +22.0% |
| Nov 7 | Roth MKM | Maintains | Buy → Buy | — | $7.37 | $8.00 | +8.5% | +21.7% | +24.3% | +35.5% | +21.6% | +14.0% |
| Aug 8 | Roth MKM | Maintains | Buy → Buy | — | $4.50 | $4.70 | +4.4% | +0.0% | -1.1% | -2.7% | +0.2% | -3.1% |
| May 9 | Canaccord Genuity | Maintains | Buy → Buy | — | $2.64 | $2.91 | +10.2% | +4.9% | +1.9% | +1.5% | +1.5% | -1.5% |
| May 9 | Roth MKM | Upgrade | Neutral → Buy | — | $2.64 | $2.91 | +10.2% | +4.9% | +1.9% | +1.5% | +1.5% | -1.5% |
| Mar 13 | Roth MKM | Maintains | Neutral → Neutral | — | $0.93 | $1.31 | +40.9% | +104.3% | +157.0% | +245.2% | +176.3% | +150.5% |
| Mar 9 | Canaccord Genuity | Maintains | Buy → Buy | — | $3.99 | $4.01 | +0.5% | -4.0% | -8.0% | -16.5% | -23.3% | -24.6% |
| Jan 4 | Roth Capital | Downgrade | Buy → Neutral | — | $13.56 | $13.73 | +1.3% | +2.9% | +0.0% | +3.7% | -4.1% | -11.9% |
| Aug 12 | Roth Capital | Downgrade | Buy → Neutral | — | $24.66 | $22.19 | -10.0% | -19.2% | -12.8% | -11.9% | -12.8% | -20.4% |
| Aug 11 | Roth Capital | Downgrade | Buy → Neutral | — | $24.46 | $24.48 | +0.1% | +0.8% | -18.5% | -12.1% | -11.2% | -12.1% |
Recent Filings
8-K · 7.01
! Medium
Laird Superfood, Inc. -- 8-K 7.01: Regulation FD Disclosure
Laird Superfood disclosed a presentation regarding its Terrasoul Acquisition, providing summary information for investors to contextualize the deal alongside SEC filings and future announcements.
Apr 22
8-K · 2.01
!!! Very High
Laird Superfood, Inc. -- 8-K 2.01: Acquisition Completed
Laird Superfood completed its acquisition of Nexus Capital Management, expanding its business portfolio and potentially enhancing investment capabilities for shareholders.
Apr 21
8-K · 2.01
!!! Very High
Unknown — 8-K 2.01: Acquisition Completed
LSF completed an acquisition that expands its asset base and diversifies its investment portfolio, potentially increasing future management fees and earnings power for shareholders.
Apr 6
8-K
Unknown — 8-K Filing
Laird Superfood achieved 15% revenue growth to $49.9M in fiscal 2025, demonstrating solid operational momentum that could justify valuation if profitability improves alongside sales expansion.
Mar 26
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
Executive severance provisions create contingent liabilities and signal potential leadership transition risk, which investors should monitor as management changes can significantly impact company strategy and stock performance.
Mar 19
8-K · 2.01
!!! Very High
Unknown — 8-K 2.01: Acquisition Completed
Ligand Pharmaceuticals completed an asset acquisition that could expand its portfolio and revenue streams, making the stock potentially more attractive if the acquired assets have strong commercial prospects.
Mar 12
Data updated apr 25, 2026 7:56pm
· Source: massive.com